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Background/aim: Acetaminophen (APAP), used in the composition of thousands of preparations, is the most commonly used analgesic
and antipyretic drug. The present study aimed to investigate the potential protective effects of the betulinic acid (BA) treatment through
an APAP-induced hepatotoxicity rat model, using inflammatory, biochemical, and histopathological parameters.
Materials and methods: The study consisted of four groups: control group, APAP group, BA group, and APAP+BA group. Experimental
studies continued for fifteen days. Serum samples were analysed for glucose, total cholesterol (TChol), triglyceride (TG), low density
lipoprotein (LDL), high density lipoprotein (HDL), aspartate amino transferase (AST), malondialdehyde (MDA), toll-like receptor-9
(TLR-9), nuclear factor kappa B (NF-κB), and interleukin-18 (IL-18).
Results: TLR9, IL-18, NF-κB, and MDA levels increased significantly in liver injury groups. These increases considerably decreased by
the BA treatment. All groups showed immunopositivity for 8-hydroxy-2’–deoxyguanosine (8-OHdG) and interleukin (IL-1β) in the
hepatocytes, inflammatory cells, and epithelial cells of bile ducts.
Conclusion: BA can be used as an effective agent in the prevention and treatment of acute liver diseases due to its inhibitory properties
in multiple pathways and its potent antioxidant effects.
Key words: Acetaminophen, betulinic acid, interleukin-18, nuclear factor kappa B, toll-like receptor-9

1. Introduction
Acetaminophen (APAP), an ingredient of thousands
of preparations, is the most commonly used class of
analgesic and antipyretic drugs worldwide because it is
inexpensive and easily accessible [1]. APAP is also one of
the most common drugs causing poisoning and a highly
preferred agent at high doses in suicide attempts [2].
Overdose APAP causes hepatic necrosis and kidney injury
via increasing the production of reactive oxygen species
(ROS) and decreasing the activity of antioxidant enzymes
[3,4]. The pathophysiology of hepatotoxicity is associated
with inflammation, disruption of intracellular ion balance,
apoptosis, and mitochondrial dysfunction [5].
Toll-like receptors (TLRs) are transmembrane proteins
involved in the defense of the immune system against
infections, with significant roles in the production
of innate immune responses to many pathogens and
activation of the acquired immune response, along

with the production of various interleukins and other
proinflammatory cytokines [6,7]. Today, TLRs are
considered as molecules playing a key role in immune
response to infections [8]. The TLR-9 is a member of
TLR family that bears a recognition pattern for microbial
DNA. TLR-9 is also an important factor in autoimmune
diseases, and there is active research into synthetic TLR9
agonists and antagonists that help regulate autoimmune
inflammation [9]. Expression of TLR-9 is positively linked
to the secretion of proinflammatory cytokines tumor
necrosis factor-alpha (TNF-α), interleukin-18 (IL-18) and
interleukin-6 (IL-6). The TLR-9 induces inflammation via
the nuclear factor kappa B (NF-κB) pathway that initiates
pro-inflammatory reactions in the immune responses. The
TLR-9 agonists and antagonists may be useful in treatment
of a variety of inflammatory conditions [10].
The IL-18 is a proinflammatory cytokine produced
by various cells such as macrophages, epithelial cells,
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activated T lymphocytes, osteoblasts, adrenal cortex cells,
and intestinal epithelial cells, and it acts as an important
regulator of innate and acquired immune responses [11].
The TLRs and the receptor for IL-18 are required for
defence system but, if hyper-activated or not switched
off efficiently, can cause tissue damage and inflammatory
diseases. Understanding how the checks and balances
in the system are integrated to fight infection without
the network operating out of control is crucial for the
development of improved drugs to treat these diseases in
the future [11,12]. The NF-κB family consists of a group of
transcription factors playing a role in many physiological
and pathological events such as cell growth, apoptosis,
immune response, and inflammation. Activated with
various intrinsic and extrinsic stimuli, NF-κB regulates
transcription of numerous genes and plays an important
role in the development of chronic inflammatory diseases
by increasing the expression of a range of proteins
such as cytokines, chemokines, immunoglobulins, and
cell adhesion molecules [13,14]. Activation of NF-κB
under oxidative stress has been noticed in a number of
inflammatory complications. Factors/agents implicate
ROS-induced lipid peroxidation products such as lipid
aldehydes in the activation of signaling cascade, eventually
activates NF-κB [15].
Throughout the historical development, various plantderived compounds found in nature are among the most
frequently used sources for the treatment of diseases and
for the discovery and development of new drugs. Increase
in diseases generate interest in alternative medicine
along with conventional drug treatment, which includes
compounds with a high antioxidant content [16]. Betulinic
acid (BA) is a pentacyclic triterpenoid isolated from plants
growing in tropical climates and exhibiting significant
biological activities. The BA was shown to have antioxidant,
anti-inflammatory and anti-hyperlipidemic effects and
suppress tumor development via antitumor effects [17,18].
The present study aimed to investigate the potential
protective effects of the BA treatment through an APAPinduced hepatotoxicity rat model, using inflammatory,
biochemical, and histopathological parameters.
2. Materials and methods
APAP and BA were purchased from Sigma Chemical Co
(St. Louis, MO, Germany). Sprague–Dawley male rats (n =
36) weighing 200–250 g at the age of 6–8 weeks were housed
in special rooms with ambient temperature of 22 ± 2°C
and humidity of 50%–60%, under photoperiod of 12: 12 h
light: dark. The animals were given tap water and standard
diet ad libitum. At first, the animals were divided randomly
into two groups: control vs. APAP administration, and
then half of these subgroups was assigned randomly to
either remained untreated or treated with BA for 15 days.
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The BA was administered for treatment via oral gavage at
a dose of 25 mg/kg [19]. The APAP was dissolved in hot
saline and administered on the last day to produce toxic
hepatitis via a single oral gavage at a dose of 1 g/kg [20].
The APAP was administered 24 h after last BA treatment.
Intraperitoneally ketamine (80 mg/kg) and xylazine (10
mg/kg) administered rats were sacrificed at the end of the
experiment, after that, intracardiac blood samples were
taken. Blood samples were centrifuged at 3000 rpm for 10
min to separate the sera. Serum samples were analyzed for
glucose, total cholesterol (TChol), triglyceride (TG), low
density lipoprotein (LDL), high density lipoprotein (HDL),
aspartate amino transferase (AST), malondialdehyde
(MDA), TLR-9, NF-κB and IL-18 values.
Serum MDA levels were determined by the method
of Ohkawa et al. [21] based on the measurement of the
absorbance of the pink colour complex formed by MDA
with thiobarbituric acid at a wavelength of 532 nm. The
results were given in nmol/L.
TLR-9, NF-κB ve IL-18 levels were measured by using
the enzyme-linked immunoassay (ELISA) method using
a rat ELISA kit (Cusabio Technology Llc., Houston, TX
77054, USA) according to the manufacturer’s instruction.
In the ELISA method, an antigen must be immobilized
on a solid surface and then complexed with an antibody
that is linked to an enzyme. Detection is accomplished by
assessing the conjugated enzyme activity via incubation
with a substrate to produce a measureable product. The
most crucial element of the detection strategy is a highly
specific antibody–antigen interaction. Absorbances were
read at 450 nm in the ELISA reader. The TLR-9, IL-18
results were expressed as pg/mL, whereas the NF-κB result
was expressed as ng/mL.
At the end of the study, 8 animals were slaughtered
from each subgroup. The liver tissue samples were fixed
in 10% buffered formalin and routinely processed for the
histological examination by embedding in paraffin wax.
The tissue sections were cut 4 μm in thickness and stained
by the Haematoxylin-Eosin for observation under a light
microscope. They were also evaluated by high–power light
microscopic examination using an Olympus Bx51 with
a DP72 camera system. Each specimen was examined
in 10 randomly selected areas of approximately an X40
objective. The scores were derived semi-quantitatively
on the preparations from each rat and were reported as
follows: Grade 0 = – (negative); Grade 1 = +1 (mild);
Grade 2 = +2 (moderate); Grade 3 = +3 (severe); Grade 4
= +4 (most severe) [22].
Four μm sections from all of the tissue samples were
cut and processed for immunohistochemical examination
by a standard avidin-biotin-peroxidase method that
the producer described. Rabit policlonal antibodies
that react with rat 8-OHdG (sc-66036) the dilution
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of 1:200 and IL-1β antibody (Catalog No. ab9722, the
dilution of 1: 200 were used for for 60 min. A secondary
antibody was used according to the manufacturer’s
protocol (expose mouse and rabbit-specific HRP/DAB
detection IHC Kit, Abcam Cat. No. ab80436). After three
washes with 0.1% Tween 20 in PBS, the sections were
incubated with 3,3-diaminobenzidine (Dako Cytomation)
and counterstained with Mayer’s hematoxylin
(DakoCytomation, Glostrup, Denmark) [22].
Tissue sections were evaluated by high-power light
microscopic examination using an Olympus Bx51 with a
DP72 camera system. Each specimen was examined in 10
randomly selected areas of approximately an X40 objective.
The scores were derived semi-quantitatively using light
microscopy on the preparations from each rat and were
reported as follows: Grade 0 = – (negative); Grade 1 = +1
(mild); Grade 2 = +2 (moderate); Grade 3 = +3 (severe);
Grade 4 = +4 (most severe) [22].
Two–way ANOVA was used to test the main effect of
health status (healthy vs. damaged) and treatment (control
vs. betulinic acid) as well as their interaction on continuous
variables (blood biochemistry parameters). The linear

model was: Yijk= µ + HSi + Trtj + (HS x Trt)ij+ eijk, where Yijk
= response variable, µ = population mean, HS = ith health
status, Trt = jth treatment, eijk = random error, being equal
and normally distributed [N (σ, µ; 0, 1)] as determined by
Kolmogorow–Smirnow test for parametric variables and
Shapiro–Wilk test for non-parametric variables. The mean
values were compared by the least significant difference
(LSD) option when interaction terms significant. The
histopathology scores (discrete variables) were reported
in median values after the Mann–Whitney U test (Version
13.2.2; MedCalc, Ostend, Belgium). Differences at p < 0.05
were considered statsistically significant.
3. Results
Table 1 shows inflammatory markers in response to the
BA treatment upon liver injury induced by the APAP
administration. Elevations in TLR-9 (p < 0.0037), IL-18
(p < 0.0007), NF-κB (p < 0.0001), and MDA (p < 0.0001)
levels indicated accorrence of liver injury. The health status
by the treatment interaction revealed that while the BA
treatment did not change the inflammatory markers in the
healthy rats, it was effective to reduce these inflammatory

Table 1. Effect of the betulinic acid (BA) treatment on inflammatory markers on a liver injury-induced by the acetaminophen (Damaged)
in rats.
Parameters1
TLR-9
pg/mL

IL-18
pg/mL

NF-κB
ng/mL

MDA
nmol/L

Healthy

3.58 ± 0.18

0.67 ± 0.04

8.09 ± 0.50

4.94 ± 0.16

Damaged

5.39 ± 0.73

0.96 ± 0.09

12.26 ± 1.15

8.19 ± 0.50

None

5.80 ± 0.69

0.97 ± 0.09

12.4 ± 1.2

7.70 ± 0.64

BA

3.22 ± 0.24

0.68 ± 0.05

8.17 ± 0.47

5.67 ± 0.25

None

3.58 ± 0.25b

0.67 ± 0.05b

7.57 ± 0.75b

5.02 ± 0.25c

BA

3.58 ± 0.26

0.66 ± 0.05

8.75 ± 0.56

4.84 ± 0.20c

None

7.80 ± 0.91a

1.23 ± 0.10a

16.8 ± 0.8a

10.1 ± 0.4a

BA

2.97 ± 0.36b

0.70 ± 0.08b

7.76 ± 0.69b

6.26 ± 0.29b

Main groups and interaction
Health Status

Treatment

Healthy
b

b

b

Damaged

Effect

p value

Health Status

0.0037

0.0007

0.0001

0.0001

Treatment

0.0002

0.0017

0.0001

0.0001

Health Status x Treatment

0.0002

0.0027

0.0001

0.0001

Data are the least square means + standard error of a mean, generated from two-way ANOVA. Different superscripts within columns
differ in the interaction row (p < 0.05), attained by the least significant difference option in the post-Hoc test.
TLR-9: Toll-like receptor-9; IL-18: Interleukin-18; NF-κB: nuclear factor kappa B; and MDA: malondialdehyde.
1
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markers in the the APAP administrated rats. Increased
serum concentrations of metabolites (exepcet for HDL,
which increased) occurrence of liver injury in the APAP
administered rats (Table 2; p < 0.0001 for all). The health
status by the treatment interaction revealed that the BA
administration was effective to reverse elevations in the
serum concentrations in glucose (p < 0.0873), TChol (p
< 0.0154), TG (p < 0.0002), LDL (p < 0.0012), AST (p <
0.0001) and upon the APAP administration, but not to the
levels of the control group.
No histopathological lesions were determined in liver
tissues of the control group (Figure 1A). The APAP group
showed congestion and dilatation in the liver blood vessels.
Severe degeneration (vacuolar or hydrophic degeneration)
and necrosis were seen in the hepatosites and hyperplasia
of bile ducts. In addition to these changes, mononuclear
cells had infiltrated in intralobuler and portal areas to these
changes. Furthermore, fat droplets in some of hepatocytes
were observed (Table 3). Although similar lesions were
observed in the APAP + BA and BA groups, it was noted
that the severity of these lesions was highest in the APAP
group (Figures 1B, 1C, 1D).

All groups showed immunopositivity for 8-OHdG and
IL-1β in the hepatocytes, inflammatory cells, and epithelial
cells of of bile ducts. The positive reaction of 8-OHdG
(Figures 2A, 2B, 2C, 2D) and IL-1β (Figure 3A, 3B, 3C,
3D) was the highest in the APAP group and the least in the
control group.
4. Discussion
Liver, having important functions in drug metabolism, is
the major target organ for drug toxicity. Hepatotoxicity
due to drug damage is a common cause of acute liver
damage [23]. It is highly important to elucidate the
mechanisms of action of hepatotoxicity, posing a risk for
mortality, for the biological follow-up of toxic substances
and developing treatment methods. Acetaminophen
causes lethal hepatocellular necrosis in experimental and
clinical studies, whether it is used at therapeutic doses or
at high doses [24].
Laboratory tests used in the diagnosis, follow-up and
treatment of liver diseases indicate liver damage and
functional status of the liver and they are called routine
liver tests. The AST is one of the significant parameters

Table 2. Effect of the betulinic (BA) acid treatment on metabolic profile on a liver injury-induced by the acetaminophen (Damaged) in
rats.
Parameters1
Glucose
mg/dL

TChol
mg/dL

TG
mg/dL

HDL
mg/dL

LDL
mg/dL

AST
U/L

Healthy

105 ± 3

151 ± 5

104 ± 8

52.7 ± 1.8

77.3 ± 5.1

45.9 ± 3.0

Damaged

74.0 ± 4.6

208 ± 9

184 ± 15

41.1 ± 4.1

131 ± 9

118 ± 13

None

76.8 ± 5.6

190 ± 12

156 ± 21

38.4 ± 3.7

120 ± 12

110 ± 16

BA

99.8 ± 3.8

174 ± 7

140 ± 6

55.1 ± 2.0

92.6 ± 5.8

60.1 ± 6.0

None

97.4 ± 4.0b

146 ± 7c

82.5 ± 9.1c

53.7 ± 2.5b

75.9 ± 7.5c

45,6 ± 4,6c

BA

114 ± 3a

157 ± 6c

132 ± 5b

51.4 ± 2.7b

79.1 ± 7.0c

46.4 ± 4.0c

None

58.3 ± 4.9d

229 ± 14a

223 ± 23a

24.5 ± 1.8b

160 ± 10a

167 ± 12a

BA

89.7 ± 3.4

186 ± 10

146 ± 10

57.7 ± 2.6

102 ± 7

69.7 ± 8.6b

Main groups and interaction
Health Status

Treatment

Healthy

Damaged
c

b

b

a

b

Effect

p value

Health Status

0.0001

0.0001

0.0001

0.0001

0.0001

0.0001

Treatment

0.0001

0.1341

0.3868

0.0001

0.0032

0.0001

Health Status x Treatment

0.0873

0.0154

0.0002

0.0001

0.0012

0.0001

Data are the least square means + standard error of a mean, generated from two-way ANOVA. Different superscripts within columns
differ in the interaction row (p < 0.05), attained by the least significant difference option in the post-Hoc test.
TChol: Total cholesterol; TG: Triglyceride (TG); HDL: High-density lipoprotein; LDL: Low-density lipoprotein; and AST: Aspartate
amino transferase.
1
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Figure 1. Effect of the betulinic (BA) acid treatment on histopathological evaluation of a liver injury-induced by the
acetaminophen (APAP) in rats. A) No histopathological lesions in the control group (Group Control). Degenerative changes
and necrosis in the hepatocytes (star), inflammation cells (arrow), B) Mild (BA group), C) Severe (group APAP), D) Moderate
(APAP+BA), HXE, Bar: 40 μm.

of liver cell damage and a routine liver test assessing also
the presence, character, and treatment response of liver
toxicity. In our study, we observed that serum AST levels
were increased by the APAP administration and decreased
by the BA treatment, which are in agreement with
previous studies [25,26]. Upon the APAP administration,
catabolic profile existed, as reflected by increases in serum
glucose, TChol, TG, and LDL levels and a decrease in
serum HDL levels. The hpperlipidemic effect of the APAP
administration may reflect the deterioration of liver cells
to metabolize lipids or lipid peroxidation. The increase
in serum lipids may be attributed to the increased liver
synthesis and/or diminished liver degradation; reduced
lipoprotein lipase activity plays a role in the lipids

increment [27].
The liver itself is affected by the toxicities mostly, due
to its metabolic functions, and endogenous antioxidant
defense mechanisms fail and undesirable severe clinical
conditions develop. Lipid peroxidation products increasing
due to tissue damage in toxic hepatitis may interfere
with various biomolecules at the site of damage and may
interfere with the functions of these biomolecules [28].
Lipid peroxidation was also suggested to play an important
role in the APAP-induced hepatotoxicity. Aktaş et al. [29]
reported that both plasma and liver MDA levels increased
in toxic hepatitis induced by the APAP administration,
which is attributed to free radicals’ production caused by
weakening of antioxidant system.
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Table 3. The semi-quantitative histopathological evalution of the hepatocytes in response to the betulinic acid (BA) treatment upon a
liver injury-induced by the acetaminophen (Damaged) in rats.
Parameters1
Main groups and interaction

Degenerative necrosis

Inflammatory cells

Bilier hyperpathia 8-OHdG

IL-1β

Healthy

0.5 (0–2)

0.0 (0–2)

0.0 (0–1)

0.5 (0–2)

0.5 (0–2)

Damaged

3.0 (2–4)

2.5 (1–4)

2.0 (0–3)

2.0 (0–3)

3.0 (2–4)

None

2.0 (0–4)

1.5 (0–4)

1.0 (0–3)

1.5 (0–3)

1.5 (0–4)

BA

2.0 (0-)

1.0 (0–3)

1.0 (0–3)

1.0 (0–3)

2.0 (0–3)

None

0.0 (0–0)d

0.0 (0–3)c

0.0 (0–3)b

0.5 (0–3)c

0.0 (0–4)d

BA

1.0 (0–2)c

0.5 (0–3)c

0.5 (0–3)b

0.5 (0–3)c

1.0 (0–3)c

None

3.5 (2–4)a

3.0 (1–4)a

2.5 (0–3)a

3.0 (2–3)a

3.0 (2–4)a

BA

2.5 (2–4)

2.0 (0–4)

2.0 (0–3)

1.5 (0–3)

2.5 (0–4)b

Health Status

Treatment

Healthy

Damaged
b

b

a

b

Effect

p Value

Health Status

0.0001

0.0001

0.0001

0.0001

0.0001

Treatment

0.7682

0.3795

0.4535

0.0018

0.5263

Health Status x Treatment

0.0001

0.0464

0.2156

0.0205

0.0001

Data are the median (min–max) values, generated from the Mann Whitney U test. Different superscripts within columns differ in the
interaction row (p < 0.05), attained by the ranking.
8-OHdG: 8-hydroxy-2’–deoxyguanosine; and IL-1β: Interleukin 1 beta.
1

Various exogenous antioxidants are used to control and
reduce increasing lipid peroxidation in living beings [30].
The BA administration significantly decreased plasma
MDA, AST, TG, TChol, and LDL levels and increased
HDL levels. In a study, Yi et al. [31] investigated the liver
protective effects of BA in alcohol induced liver damage
and reported that the BA treatment had hepatoprotective
effects. In another study it was shown that the BA treatment
was noted to significantly decrease plasma AST levels
and inhibit apoptosis in the liver [32]. It appears that the
hepatoprotective mechanism is linked to BA’s antioxidant
capacity, mainly by improving the tissue redox system,
maintaining the antioxidant system, and decreasing lipid
peroxidation in the liver [33].
Activation of TLR increases the synthesis and release of
molecules, and causes tissue damage with the emergence
of free radicals, in various inflammatory events including
increase of proinflammatory cytokine levels. The cytokines
involved in the induction of immune response provide
intercellular communication and play an effective role
in influencing the severity and the maintenance of the
immune response [34]. Imaeda et al. [35] reported that
the APAP administration resulted in significant damage
in the hepatocytes. However, they noted that free DNA
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released from apoptosis-induced hepatocytes activated
TLR-9 levels, and the increased TLR-9 enhanced the
transcription of IL-18 encoding genes. In another study
conducted by Teratani et al. [36] in 2017, an increased
TLR-9 level was interpreted as an important indicator of
acute liver damage. They also reported that the severity
of liver damage increased in line with the activation of
TLR-9/inflammasome pathway. In this study the APAP
administration increased TLR-9 and IL-18 levels, as well.
NF-κB is the major modulator of all TLR signaling
mechanisms, and the activation of NF-κB plays a critical
role in TLR-mediated activation of the innate immune
response. Its rapid activation is crucial for the required
immune response, because all TLR signaling pathways
result in NF-κB activation, controlling the expression of
a number of inflammatory cytokine genes [37,38]. In an
experimental study, Zhang et al. [39] induced liver fibrosis
by carbontetra chloride (CCl4) and noted that NF-κB
and TLR-4 increased mRNA levels. The ROS-induced
lipid peroxidation products such as lipid aldehydes in the
activation of signaling cascade eventually activates NF-B,
indicating that ROS-induced lipid peroxidation has been
proposed to be majör contributor in the pathophysiology
of many inflammatory disorders [40]. In this experiment,

DOKUMACIOĞLU et al. / Turk J Med Sci

Figure 2. Effect of the betulinic (BA) acid treatment on immunohistochemstry of a liver injury-induced by the acetaminophen
(APAP) in rats. Immunohistochemstry stain; immunopositivity for 8-OHdG in the hepatocytes (arow). A) Mild (Group
Control), B) Mild (BA group), C) Severe (group APAP), D) Moderate (APAP+BA), Bar: 40 μm.

the APAP administration resulted in significant increase
in TLR-9, NF-κB and IL-18 levels as well, accompanied by
increases in MDA levels, in agreement with the literature
[41]. Elevations in these molecular parameters were
reversed by the BA treatment. There are not many studies
in the literature investigating the effects of the BA treatment
on liver damage. Liu et al. [42] stated that BA exerted
hepatoprotective effects through autophagy, suggesting
that it could be used as a new agent in the treatment of
hepatic fibrosis. This beneficial effect is related to its
high antioxidant capacity to suppress lipid peroxidation
and activate the endogenous antioxidant system [43]. In
an experimental study examining the effects of BA on
renal fibrosis, it was reported that BA prevents fibrosis
by inhibiting NF-κB activation [44]. The present findings
reinforce the potential of BA, a natural compound as an

anti-inflammatory drug candidate consider the role of
TLR-9/NF-κB /IL-18 as another important mediator
involved in the immune regulation produced by the APAP
and indicate the carrying out of future clinical evaluations
involving BA effect on severe liver diseases.
The hepatotoxicity of APAP reflected with sinusoidal
dilatation, necrosis, and inflammatory cell infiltration
in microscopic evaluation of liver tissue, which were
evident in this experiment. The BA treatment is alleviated
these adverse consequences of the APAP administration.
8-OHdG is another pathway to detect damages caused by
ROS in the cell. 8-OHdG is known as an important indicator
of DNA damage due to oxidative stress that can be induced
by ROS and also a sign of cellular oxidative stress in DNA
degradation [45]. IL-1β is one of the major mediators of
chronic inflammatory diseases. Immunohistochemical
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Figure 3. Effect of the betulinic (BA) acid treatment on immunohistochemstry of a liver injury-induced by the acetaminophen
(APAP) in rats. Immunohistochemstry stain; immunopositivity for IL-1β in the hepatocytes (arow), A) Mild (Group Control),
B) Mild (BA group), C) Severe (group APAP), D) Moderate (APAP+BA), Bar: 40 μm.

analysis revelated that the APAP administration activated
8-OHdG and IL-1 β in liver tissue. It was observed that
8-OHdG and IL-1β staining was minimal in BA-treated rat
livers.
5. Conclusion
In summary, APAP-induced acute liver damage is a serious
clinical problem with high morbidity and mortality
caused by oxidative stress and diffuse inflammation.
Regarding pathophysiology of liver injury, TLR-9 had an
important role in the initiation of hyperinflammation and
development of tissue damage, which triggered NF-κB and
IL-18 activation. The BA treatment inhibited TLR-9/NFκB /IL-18 and lipid peroxidation for alleviation of tissue
damage. Therefore, BA can be used as an effective agent in
the prevention and treatment of acute liver diseases, due
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to its inhibitory properties in multiple pathways and its
potent antioxidant effects.
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